BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
BioScience Health Innovations, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.78+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $79.22M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$2.78 (+69.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
BioScience Health Innovations, Inc. grew revenue 7.8% to $4.49M over the twelve months to Jun 30, 2026. Operating income fell 164.5% to -$613.24K, moving the operating margin from 22.8% to -13.7%.
Revenue
$4.49M
+7.8% vs. a year earlier
Operating income
-$613.24K
-164.5% vs. a year earlier
EPS, diluted
-$0.06
-200.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $79.22M
- P/E ratio
- –
- Price to sales
- 17.64
- Price to book
- 43.17
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.49M
- Net income
- -$658.07K
- EPS, diluted
- -$0.06
- Book value per share
- $0.16
- Diluted shares
- 12M
Six years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$4.49M+7.8% YoY
Gross profit
$2.42M-11.7% YoY
Operating income
-$613.24K-164.5% YoY
Net income
-$658.07K-169.2% YoY
EPS, diluted
-$0.06-200.0% YoY
Reported periodTrailing twelve months